FDA panel narrowly backs Medtronic spine device

Related posts:

  1. U.S. panel narrowly backs Photocure cancer test drug
  2. Senators probe Medtronic on spine surgery product
  3. Medtronic hires Yale experts for spine drug review
  4. Medtronic heart device has safety issues: FDA staff
  5. Minn. judge dismisses Medtronic heart device suits